Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sooam Biotech Research Foundation is a South Korean biotechnology organization specializing in animal cloning and stem cell research. Founded in 2006 by Dr. Hwang Woo-suk, the foundation is most famous for its commercial dog cloning services, which cater to pet owners and government agencies worldwide. Beyond pet cloning, Sooam is deeply involved in the cloning of livestock and the preservation of endangered species through somatic cell nuclear transfer (SCNT) technology. The foundation also conducts biomedical research, focusing on the production of transgenic animals for disease modeling and potential xenotransplantation. Despite the controversial history of its founder, Sooam remains a leading center for advanced reproductive biotechnologies. Its facilities in Seoul serve as a hub for both commercial operations and international research collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sooam Biotech Research Foundation.